Literature DB >> 25338279

Intravitreal aflibercept treatment of retinal angiomatous proliferation: a pilot study and short-term efficacy.

Konstantinos T Tsaousis1, Vasileios E Konidaris, Somnath Banerjee, Theodoros Empeslidis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25338279     DOI： 10.1007/s00417-014-2835-8

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Intravitreal bevacizumab versus ranibizumab for the treatment of retinal angiomatous proliferation.

Authors:  Maurizio B Parodi; Pierluigi Iacono; Francesca Menchini; Saumil Sheth; Giovanni Polini; Raffaele Pittino; Francesco Bandello
Journal:  Acta Ophthalmol       Date:  2011-09-22       Impact factor: 3.761

2.  Retinal angiomatous proliferation in age-related macular degeneration.

Authors:  L A Yannuzzi; S Negrão; T Iida; C Carvalho; H Rodriguez-Coleman; J Slakter; K B Freund; J Sorenson; D Orlock; N Borodoker
Journal:  Retina       Date:  2001       Impact factor: 4.256

3.  Intravitreal ranibizumab treatment of retinal angiomatous proliferation.

Authors:  Christina A Kramann; Kilian Schöpfer; Katrin Lorenz; Isabella Zwiener; Bernhard M Stoffelns; Norbert Pfeiffer
Journal:  Acta Ophthalmol       Date:  2010-06-24       Impact factor: 3.761

4.  Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study.

Authors:  Jean-François Korobelnik; Frank G Holz; Johann Roider; Yuichiro Ogura; Christian Simader; Ursula Schmidt-Erfurth; Katrin Lorenz; Miki Honda; Robert Vitti; Alyson J Berliner; Florian Hiemeyer; Brigitte Stemper; Oliver Zeitz; Rupert Sandbrink
Journal:  Ophthalmology       Date:  2013-09-29       Impact factor: 12.079

5.  Intravitreal aflibercept injection for neovascular age-related macular degeneration: ninety-six-week results of the VIEW studies.

Authors:  Ursula Schmidt-Erfurth; Peter K Kaiser; Jean-François Korobelnik; David M Brown; Victor Chong; Quan Dong Nguyen; Allen C Ho; Yuichiro Ogura; Christian Simader; Glenn J Jaffe; Jason S Slakter; George D Yancopoulos; Neil Stahl; Robert Vitti; Alyson J Berliner; Yuhwen Soo; Majid Anderesi; Olaf Sowade; Oliver Zeitz; Christiane Norenberg; Rupert Sandbrink; Jeffrey S Heier
Journal:  Ophthalmology       Date:  2013-09-29       Impact factor: 12.079
  5 in total
  5 in total

1.  [Intravitreal ranibizumab for the treatment of retinal angiomatous proliferation].

Authors:  J Maaß; D Sandner; E Matthé
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

2.  Short-term efficacy of intravitreal Aflibercept injections for retinal angiomatous proliferation.

Authors:  Hung-Da Chou; Wei-Chi Wu; Nan-Kai Wang; Lan-Hsin Chuang; Kuan-Jen Chen; Chi-Chun Lai
Journal:  BMC Ophthalmol       Date:  2017-06-27       Impact factor: 2.209

3.  Case Report: A Case of Perifoveal Exudative Vascular Anomalous Complex With a Good Prognosis.

Authors:  Min Fu; Pan Hu; Gang Zhang; Ludonghan Huang; Huan Xu; Ju Huang; Meihui Wu; Yanli Chen
Journal:  Front Med (Lausanne)       Date:  2021-12-13

4.  A Case of Chorioretinitis with Retinal Angiomatous Proliferation.

Authors:  Yanru Chen; Mingyan Wei; Qian Chen; Minghan Li
Journal:  Case Rep Ophthalmol Med       Date:  2021-12-26

Review 5.  Treatment of Exudative Age-related Macular Degeneration: Focus on Aflibercept.

Authors:  Alfredo García-Layana; Marta S Figueroa; Javier Araiz; José M Ruiz-Moreno; Francisco Gómez-Ulla; Luis Arias-Barquet; Nicholas Reiter
Journal:  Drugs Aging       Date:  2015-10       Impact factor: 3.923
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.